LEP and metabolic dysfunction-associated steatotic liver disease: This is specifically reflected in the sustained down-regulation of de novo lipogenesis genes and TG accumulation in nonalcoholic fatty liver disease (NAFLD) animal models and leptin-deficient mice after histidine treatment [97].